Kura Oncology to Participate in Three Upcoming Investor Conferences
Kura Oncology (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on precision medicines for cancer treatment, has announced its participation in three major investor conferences in September 2025.
The company will present at the Cantor Global Health Conference on September 4 at 8:35 a.m. ET, the H.C. Wainwright Global Investment Conference on September 8 at 1:00 p.m. ET, and the Morgan Stanley Global Healthcare Conference on September 10 at 1:50 p.m. ET. Live webcasts will be available on Kura's website with archived replays accessible after the events.
Kura Oncology (NASDAQ:KURA), azienda biofarmaceutica in fase clinica specializzata in terapie di precisione per il trattamento del cancro, ha comunicato la sua partecipazione a tre importanti conferenze per investitori a settembre 2025.
La società presenterà al Cantor Global Health Conference il 4 settembre alle 8:35 ET, all'H.C. Wainwright Global Investment Conference l'8 settembre alle 13:00 ET e al Morgan Stanley Global Healthcare Conference il 10 settembre alle 13:50 ET. Le dirette in webcast saranno disponibili sul sito di Kura e le registrazioni potranno essere riascoltate dopo gli eventi.
Kura Oncology (NASDAQ:KURA), una compañía biofarmacéutica en fase clínica centrada en medicamentos de precisión para el tratamiento del cáncer, ha anunciado su participación en tres importantes conferencias para inversores en septiembre de 2025.
La empresa realizará presentaciones en el Cantor Global Health Conference el 4 de septiembre a las 8:35 a.m. ET, en el H.C. Wainwright Global Investment Conference el 8 de septiembre a la 1:00 p.m. ET y en el Morgan Stanley Global Healthcare Conference el 10 de septiembre a la 1:50 p.m. ET. Habrá retransmisiones en directo disponibles en la web de Kura y las repeticiones quedarán archivadas tras los eventos.
Kura Oncology (NASDAQ:KURA)는 암 치료를 위한 정밀 의약품 개발에 주력하는 임상 단계의 바이오제약사로, 2025년 9월에 개최되는 주요 투자자 컨퍼런스 세 곳에 참가한다고 발표했습니다.
회사는 Cantor Global Health Conference에 9월 4일 오전 8시 35분(ET), H.C. Wainwright Global Investment Conference에 9월 8일 오후 1시(ET), Morgan Stanley Global Healthcare Conference에 9월 10일 오후 1시 50분(ET)에 발표를 진행합니다. 생중계 웹캐스트는 Kura 웹사이트에서 제공되며, 행사 후에는 다시보기 아카이브도 확인할 수 있습니다.
Kura Oncology (NASDAQ:KURA), une société biopharmaceutique en phase clinique spécialisée dans les médicaments de précision pour le traitement du cancer, a annoncé sa participation à trois grandes conférences investisseurs en septembre 2025.
La société présentera au Cantor Global Health Conference le 4 septembre à 8h35 ET, au H.C. Wainwright Global Investment Conference le 8 septembre à 13h00 ET et au Morgan Stanley Global Healthcare Conference le 10 septembre à 13h50 ET. Des webcasts en direct seront disponibles sur le site de Kura et les rediffusions seront archivées après les événements.
Kura Oncology (NASDAQ:KURA), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Präzisionsmedikamente zur Krebsbehandlung spezialisiert hat, gab seine Teilnahme an drei wichtigen Investorenkonferenzen im September 2025 bekannt.
Das Unternehmen wird auf der Cantor Global Health Conference am 4. September um 8:35 Uhr ET, auf der H.C. Wainwright Global Investment Conference am 8. September um 13:00 Uhr ET und auf der Morgan Stanley Global Healthcare Conference am 10. September um 13:50 Uhr ET präsentieren. Live-Webcasts sind auf der Website von Kura verfügbar, Aufzeichnungen werden nach den Veranstaltungen archiviert.
- None.
- None.
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that management is scheduled to participate in three investor conferences in September.
Cantor Global Health Conference
Thursday, September 4, 2025
8:35 a.m. ET / 5:35 a.m. PT
H.C. Wainwright 27th Annual Global Investment Conference
Monday, September 8, 2025
1:00 p.m. ET / 10:00 a.m. PT
Morgan Stanley 23rd Annual Global Healthcare Conference
Wednesday, September 10, 2025
1:50 p.m. ET / 10:50 a.m. PT
Live audio webcasts will be available in the Investors section of Kura’s website at https://kuraoncology.com/, with archived replays available following all three events.
About Kura Oncology
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline of small molecule drug candidates is designed to target cancer signaling pathways and address high-need hematologic malignancies and solid tumors. Kura is developing ziftomenib, a menin inhibitor targeting certain genetic drivers of acute myeloid leukemias and continues to pioneer advancements in both menin inhibition and farnesyl transferase inhibition to address mechanisms of adaptive and innate resistance in the treatment of solid tumors. For additional information, please visit the Kura website at https://kuraoncology.com/ and follow us on X and LinkedIn.
Contacts
Investors and media:
Greg Mann
858-987-4046
gmann@kuraoncology.com
FAQ
When is Kura Oncology (KURA) presenting at the Cantor Global Health Conference 2025?
How can investors access Kura Oncology's (KURA) conference presentations in September 2025?
Which investor conferences will Kura Oncology (KURA) attend in September 2025?
What time is Kura Oncology's (KURA) presentation at the Morgan Stanley Healthcare Conference?
